Screener
Ocular Therapeutix OCUL Total Cost of Revenue
Total Cost of Revenue at other companies
Segments
By segment
Other financials
Where this comes from
Reported directly by Ocular Therapeutix in its filing.
Tagged under the XBRL concept us-gaap:CostOfGoodsAndServicesSold.
The source filing: Ocular Therapeutix’s 10-Q, filed May 5, 2026.
- Filed
- May 5, 2026, 7:28 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001104659-26-055256
| Line item | Three Months Ended / March 31, 2026 | Three Months Ended / March 31, 2025 |
|---|---|---|
| Collaboration revenue | — | 64 |
| Total revenue, net | 10,785 | 10,698 |
| Costs and operating expenses: | ||
| Cost of product revenue | 1,329 | 1,262 |
| Research and development | 66,213 | 42,857 |
| Selling and marketing | 16,577 | 14,148 |
| General and administrative | 20,006 | 16,348 |
| Total costs and operating expenses | 104,125 | 74,615 |
Item 1. Financial Statements (unaudited)
FAQ
- What is Ocular Therapeutix's total cost of revenue?
- Ocular Therapeutix (OCUL) reported total cost of revenue of $1.33M in Q1 2026.
- How has Ocular Therapeutix's total cost of revenue changed year-over-year?
- Ocular Therapeutix's total cost of revenue increased by 5.3% year-over-year, from $1.26M to $1.33M.
- What is the long-term trend for Ocular Therapeutix's total cost of revenue?
- Over 4 years (2021 to 2025), Ocular Therapeutix's total cost of revenue has grown at a 10.5% compound annual growth rate (CAGR), from $4.41M to $6.57M.
- What does total cost of revenue mean?
- The aggregate of all direct costs attributable to producing goods and delivering services that generated the company's revenue, including materials, labor, and overhead.
Ask your AI about Ocular Therapeutix's total cost of revenue.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude